MCID: INP001
MIFTS: 45

Inappropriate Adh Syndrome

Categories: Endocrine diseases

Aliases & Classifications for Inappropriate Adh Syndrome

MalaCards integrated aliases for Inappropriate Adh Syndrome:

Name: Inappropriate Adh Syndrome 12 44 15 73
Syndrome of Inappropriate Secretion of Antidiuretic Hormone 12 37
Syndrome of Inappropriate Antidiuretic Hormone Secretion 12
Syndrome of Inappropriate Vasopressin Secretion 12
Syndrome of Inappropriate Secretion of Adh 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3401
ICD10 33 E22.2
MeSH 44 D007177
NCIt 50 C3988
SNOMED-CT 68 55004003
KEGG 37 H01682
UMLS 73 C0021141

Summaries for Inappropriate Adh Syndrome

MalaCards based summary : Inappropriate Adh Syndrome, also known as syndrome of inappropriate secretion of antidiuretic hormone, is related to syndrome of inappropriate antidiuretic hormone and nephrogenic syndrome of inappropriate antidiuresis, and has symptoms including polyuria An important gene associated with Inappropriate Adh Syndrome is AVP (Arginine Vasopressin), and among its related pathways/superpathways are Neuroactive ligand-receptor interaction and Vasopressin-regulated water reabsorption. The drugs Tolvaptan and Empagliflozin have been mentioned in the context of this disorder. Affiliated tissues include pituitary, kidney and lung, and related phenotypes are behavior/neurological and growth/size/body region

Wikipedia : 76 Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by excessive... more...

Related Diseases for Inappropriate Adh Syndrome

Diseases related to Inappropriate Adh Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 215)
# Related Disease Score Top Affiliating Genes
1 syndrome of inappropriate antidiuretic hormone 32.6 AQP2 AVP AVPR2 POMC
2 nephrogenic syndrome of inappropriate antidiuresis 32.4 AVP AVPR2
3 lung oat cell carcinoma 30.6 AVP POMC
4 diabetes insipidus 30.1 AQP2 AVP AVPR2 POMC REN
5 liver cirrhosis 30.0 AQP2 AVP REN
6 hypokalemia 30.0 AQP2 POMC REN
7 lymphoma 10.6
8 lung cancer 10.5
9 lupus erythematosus 10.5
10 herpes zoster 10.5
11 systemic lupus erythematosus 10.4
12 prostate cancer 10.4
13 small cell cancer of the lung 10.4
14 neuroblastoma 10.4
15 squamous cell carcinoma 10.4
16 olfactory neuroblastoma 10.4
17 meningitis 10.4
18 brucellosis 10.3
19 neuromyelitis optica 10.3
20 tuberculous meningitis 10.3
21 myeloma, multiple 10.2
22 suppression of tumorigenicity 12 10.2
23 lateral medullary syndrome 10.2
24 craniopharyngioma 10.2
25 status asthmaticus 10.2
26 breast cancer 10.2
27 porphyria, acute intermittent 10.2
28 schizophrenia 10.2
29 brain injury 10.2
30 small cell carcinoma 10.2
31 porphyria 10.2
32 melanoma 10.2
33 adenocarcinoma 10.2
34 thymoma 10.2
35 herpes zoster ophthalmicus 10.2
36 diabetes insipidus, nephrogenic, x-linked 10.2 AQP2 AVPR2
37 central nervous system germinoma 10.2 AVP POMC
38 tuberculous epididymitis 10.2 AVP POMC
39 peripheral vertigo 10.2 AQP2 AVP
40 central nervous system germ cell tumor 10.2 AVP POMC
41 bronchus cancer 10.2 AVP POMC
42 vestibular disease 10.2 AQP2 AVP
43 olfactory nerve neoplasm 10.1 AVP POMC
44 secondary hypertrophic osteoarthropathy 10.1 AVP POMC
45 tuberculous empyema 10.1 AVPR2 POMC
46 cervix small cell carcinoma 10.1 AVP POMC
47 cranial nerve malignant neoplasm 10.1 AVP POMC
48 central pontine myelinolysis 10.1 AQP4 AVP
49 chromophobe adenoma 10.1 AVP POMC
50 ectopic cushing syndrome 10.1 AVPR2 POMC

Graphical network of the top 20 diseases related to Inappropriate Adh Syndrome:



Diseases related to Inappropriate Adh Syndrome

Symptoms & Phenotypes for Inappropriate Adh Syndrome

UMLS symptoms related to Inappropriate Adh Syndrome:


polyuria

MGI Mouse Phenotypes related to Inappropriate Adh Syndrome:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.87 AQP2 AQP4 AVP AVPR2 CNTNAP2 POMC
2 growth/size/body region MP:0005378 9.8 AQP2 AQP4 AVPR2 CNTNAP2 POMC REN
3 mortality/aging MP:0010768 9.7 AQP2 AQP4 AVP AVPR2 POMC REN
4 nervous system MP:0003631 9.43 AQP4 AVP CNTNAP2 POMC REN SNAI1
5 renal/urinary system MP:0005367 9.1 AQP2 AQP4 AVP AVPR2 POMC REN

Drugs & Therapeutics for Inappropriate Adh Syndrome

Drugs for Inappropriate Adh Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tolvaptan Approved Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable 150683-30-0 216237
2
Empagliflozin Approved Phase 2, Phase 3,Phase 3 864070-44-0
3 Hormones Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
4 Arginine Vasopressin Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
5 Natriuretic Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
6 Vasopressins Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
7 Vasoconstrictor Agents Phase 3,Phase 2,Phase 1
8 arginine Phase 3,Phase 2,Phase 1
9 Hormone Antagonists Phase 3,Phase 2,Phase 1
10 Coagulants Phase 3,Phase 2,Phase 1
11
Satavaptan Phase 3,Phase 2 185913-78-4 7029
12 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
13 Hemostatics Phase 3,Phase 2,Phase 1
14 Hypoglycemic Agents Phase 2, Phase 3,Phase 3
15 Deamino Arginine Vasopressin Phase 2, Phase 3
16 Pharmaceutical Solutions Phase 2, Phase 3
17
Probenecid Approved, Investigational Phase 1, Phase 2 57-66-9 4911
18
Acetylcysteine Approved, Investigational Phase 1, Phase 2 616-91-1 12035
19 Antioxidants Phase 1, Phase 2
20 Antiviral Agents Phase 1, Phase 2
21 Anti-Infective Agents Phase 1, Phase 2
22 Expectorants Phase 1, Phase 2
23 N-monoacetylcystine Phase 1, Phase 2
24 Antidotes Phase 1, Phase 2
25 Free Radical Scavengers Phase 1, Phase 2
26 Antirheumatic Agents Phase 1, Phase 2
27 Renal Agents Phase 1, Phase 2
28 Protective Agents Phase 1, Phase 2
29 Respiratory System Agents Phase 1, Phase 2
30 cysteine Phase 1, Phase 2

Interventional clinical trials:

(show all 22)
# Name Status NCT ID Phase Drugs
1 Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine Withdrawn NCT00298753 Phase 4
2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia Unknown status NCT01507727 Phase 2, Phase 3 Tolvaptan;Placebo
3 Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Completed NCT00264914 Phase 3 SR121463B
4 Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Completed NCT00264927 Phase 3 SR121463B
5 Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study Completed NCT02729766 Phase 2, Phase 3 Empagliflozin 25mg Tbl;Placebo P-Tablet
6 "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia Completed NCT00201994 Phase 3 Tolvaptan
7 “SALT Trial” Study of Ascending Levels of Tolvaptan in Hyponatremia Completed NCT00072683 Phase 3 tolvaptan
8 A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH Recruiting NCT03048747 Phase 3 Tolvaptan Oral Tablet
9 Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study Recruiting NCT03202667 Phase 2, Phase 3 Empagliflozin 25mg;Placebo
10 Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study Enrolling by invitation NCT02874807 Phase 2, Phase 3 Empagliflozin
11 A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Terminated NCT00728091 Phase 3 Satavaptan;placebo
12 Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Terminated NCT01227512 Phase 3 tolvaptan
13 Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Completed NCT00032734 Phase 2 satavaptan (SR121463B)
14 A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Completed NCT02009878 Phase 1, Phase 2 tolvaptan
15 Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury Completed NCT01322009 Phase 1, Phase 2 Probenecid and N-acetyl cysteine;Placebo
16 Subclassification of the Syndrome of Inappropriate ADH Secretion Completed NCT01341665
17 An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH Completed NCT02545101
18 An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain Completed NCT02548845
19 An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy Completed NCT02573077
20 Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Completed NCT01240668
21 Evaluation of Plasma Volume Using Ultrasound in Disorders of Fluid With Sodium Active, not recruiting NCT01547650
22 Fractional Urate Excretion in Nonedematous Hyponatremia Withdrawn NCT01425125 Not Applicable Tolvaptan in euvolemic hyponatremia

Search NIH Clinical Center for Inappropriate Adh Syndrome

Cochrane evidence based reviews: inappropriate adh syndrome

Genetic Tests for Inappropriate Adh Syndrome

Anatomical Context for Inappropriate Adh Syndrome

MalaCards organs/tissues related to Inappropriate Adh Syndrome:

41
Pituitary, Kidney, Lung, Liver, B Cells, Myeloid, Pancreas

Publications for Inappropriate Adh Syndrome

Articles related to Inappropriate Adh Syndrome:

(show top 50) (show all 252)
# Title Authors Year
1
A Case of Neurosarcoidosis-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone Diagnosed with Neuroendoscopy. ( 30158982 )
2018
2
Syndrome of Inappropriate Secretion of Antidiuretic Hormone and Hyponatremia. ( 29292284 )
2018
3
Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan. ( 29478867 )
2018
4
Tolvaptan for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone: Is the Dose Too High? ( 29801549 )
2018
5
Severe Solute Depletion in Patients with Hyponatremia Due to Diuretics Despite Biochemical Pictures Similar Than Those Observed in the Syndrome of Inappropriate Secretion of Antidiuretic Hormone. ( 29990986 )
2018
6
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Preceding Guillain-Barré Syndrome. ( 29207765 )
2017
7
Localized herpes zoster infection: a rare cause of syndrome of inappropriate secretion of antidiuretic hormone. ( 29230301 )
2017
8
Successful Radiotherapy for Advanced Small Cell Carcinoma of the Prostate with Syndrome of Inappropriate Secretion of Antidiuretic Hormone. ( 28567332 )
2017
9
Mild Lung Tuberculosis in a Patient Suffering from Status Epilepticus Caused by the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH). ( 28202866 )
2017
10
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient. ( 28271051 )
2017
11
Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis. ( 28604351 )
2017
12
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to bortezomib in a case of light chain multiple mieloma. Treatment with tolvaptan. ( 28946972 )
2017
13
Erratum to: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with lateral medullary syndrome: case report and literature review. ( 27716174 )
2016
14
Syndrome of inappropriate secretion of antidiuretic hormone in a patient with drug-induced hypersensitivity syndrome. ( 25688750 )
2016
15
Quetiapine-Induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone. ( 27034875 )
2016
16
The Syndrome of Inappropriate Secretion of AntiDiuretic Hormone in Patients With Brucellosis. ( 24889373 )
2015
17
Case of inappropriate ADH syndrome: hyponatremia due to polyethylene glycol bowel preparation. ( 25232272 )
2014
18
Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report. ( 24944702 )
2014
19
Alternating syndrome of inappropriate secretion of antidiuretic hormone and cerebral salt wasting in an infant with brain tumor. ( 23171995 )
2014
20
Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm. ( 24739604 )
2014
21
Possible association of syndrome of inappropriate secretion of antidiuretic hormone with St John's wort use. ( 25203466 )
2014
22
Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan. ( 23761568 )
2013
23
Syndrome of inappropriate secretion of antidiuretic hormone associated with angiotensin-converting enzyme inhibitor administration. ( 22622687 )
2013
24
Syndrome of inappropriate secretion of antidiuretic hormone due to desvenlafaxine. ( 22818163 )
2013
25
Use of conivaptan for refractory syndrome of inappropriate secretion of antidiuretic hormone in a pediatric patient. ( 23546432 )
2013
26
Syndrome of inappropriate secretion of antidiuretic hormone due to selective serotonin reuptake inhibitors after pancreaticoduodenectomy for carcinoma of the ampulla of Vater: case report. ( 24229010 )
2013
27
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases. ( 26069838 )
2013
28
A case of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with lupus erythematosus in the central nervous system. ( 28509213 )
2013
29
A rare case of metastatic ductal type prostate adenocarcinoma presenting with syndrome of inappropriate secretion of antidiuretic hormone: a case report and review. ( 22842384 )
2012
30
Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone. ( 22250614 )
2012
31
Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug. ( 22323742 )
2012
32
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients. ( 22378162 )
2012
33
Syndrome of inappropriate secretion of antidiuretic hormone induced by tacrolimus in a patient with systemic lupus erythematosus. ( 20737184 )
2011
34
Syndrome of inappropriate secretion of antidiuretic hormone found by preoperative electrolyte analysis. ( 21257706 )
2011
35
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following carboplatin-paclitaxel administration in a patient with lung cancer. ( 22026133 )
2011
36
Syndrome of inappropriate secretion of antidiuretic hormone caused by pituitary macroadenoma with hemangiomatous stroma. ( 22167496 )
2011
37
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. ( 20064953 )
2010
38
Syndrome of inappropriate secretion of antidiuretic hormone as a leading cause of hyponatremia in children who underwent chemotherapy or stem cell transplantation. ( 20205255 )
2010
39
The syndrome of inappropriate secretion of antidiuretic hormone: diagnostic and therapeutic advances. ( 20607641 )
2010
40
Syndrome of inappropriate secretion of antidiuretic hormone and rhabdomyolysis complicating rhytidectomy. ( 20811190 )
2010
41
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). ( 20935451 )
2010
42
Syndrome of inappropriate secretion of antidiuretic hormone after endoscopic submucosal dissection for early gastric cancer. ( 26192421 )
2009
43
Syndrome of inappropriate secretion of antidiuretic hormone. ( 19279514 )
2009
44
A case of syndrome of inappropriate secretion of antidiuretic hormone following endoscopic treatment. ( 19418420 )
2009
45
Two patients with recurring syndrome of inappropriate secretion of antidiuretic hormone on multiple atypical antipsychotics. ( 19512986 )
2009
46
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). ( 19523572 )
2009
47
Thymic neuroblastoma with the syndrome of inappropriate secretion of antidiuretic hormone. ( 19661118 )
2009
48
The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT: clinical differences following SCT using cord blood and BM/peripheral blood. ( 18711342 )
2008
49
Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine. ( 17989977 )
2008
50
Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. ( 18434618 )
2008

Variations for Inappropriate Adh Syndrome

Expression for Inappropriate Adh Syndrome

Search GEO for disease gene expression data for Inappropriate Adh Syndrome.

Pathways for Inappropriate Adh Syndrome

Pathways related to Inappropriate Adh Syndrome according to KEGG:

37
# Name Kegg Source Accession
1 Neuroactive ligand-receptor interaction hsa04080
2 Vasopressin-regulated water reabsorption hsa04962

GO Terms for Inappropriate Adh Syndrome

Cellular components related to Inappropriate Adh Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 clathrin-coated vesicle membrane GO:0030665 8.62 AVP AVPR2

Biological processes related to Inappropriate Adh Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of blood pressure GO:0008217 9.46 POMC REN
2 social behavior GO:0035176 9.43 AVP CNTNAP2
3 generation of precursor metabolites and energy GO:0006091 9.4 AVP POMC
4 excretion GO:0007588 9.37 AQP2 AVPR2
5 positive regulation of vasoconstriction GO:0045907 9.32 AVP AVPR2
6 positive regulation of systemic arterial blood pressure GO:0003084 9.26 AVP AVPR2
7 multicellular organismal water homeostasis GO:0050891 9.16 AQP4 AVP
8 water transport GO:0006833 9.13 AQP2 AQP4 AVP
9 renal water homeostasis GO:0003091 8.92 AQP2 AQP4 AVP AVPR2

Molecular functions related to Inappropriate Adh Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 9.43 AVP POMC REN
2 channel activity GO:0015267 9.16 AQP2 AQP4
3 water channel activity GO:0015250 8.96 AQP2 AQP4
4 water transmembrane transporter activity GO:0005372 8.62 AQP2 AQP4

Sources for Inappropriate Adh Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....